Solvated crystalline forms of nevirapine: Thermoanalytical and spectroscopic studies

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1328-1339

  Chadha, Renu ^a   Arora, Poonam ^a   Saini, Anupam ^a   Jain, Dharamvir Singh ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

calorimetry; enthalpy of solution; heat capacity; recrystallization; solvates

Indexed keywords

CRYSTALLIN; HEMI ACETONITRILATE; HEMI CHLOROFORMATE; HEMI ETHANOLATE; HEMI THF SOLVATE; HEMI TOLUENATE; MIXED HEMI ETHANOLATE HEMI HYDRATE; NEVIRAPINE; PHOSPHATE BUFFERED SALINE; SOLVENT; UNCLASSIFIED DRUG;

ANALYSIS; ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; ENTHALPY; HEAT TOLERANCE; INFRARED SPECTROSCOPY; KARL FISCHER AQUAMETRY; MICROCALORIMETRY; PH MEASUREMENT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPY; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

COMPUTER SIMULATION; CRYSTALLIZATION; MODELS, CHEMICAL; MODELS, MOLECULAR; NEVIRAPINE; SOLVENTS; SPECTRUM ANALYSIS; THERMODYNAMICS;

EID: 78649908409     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9511-z     Document Type: Article

References (48)

1. L Borka 1991 Review on crystal polymorphism of substances in the European pharmacoepiea Pharm Acta Helv 66 16 22 1:CAS:528:DyaK3MXovVCmsw%3D%3D 1758886
2. JK Haleblian 1975 Characterization of habits and crystalline modifications of solids and their pharmaceutical applications J Pharm Sci 64 1269 88 1:CAS:528:DyaE2MXltlKkt7k%3D 10.1002/jps.2600640805 1151699
3. S Byrn R Pfeiffer M Ganey C Hoiberg JW Poole G Poochikian 1995 Pharmaceutical solids: strategic approach to regulatory considerations Pharm Res 12 945 54 1:CAS:528:DyaK2MXmvFClu7c%3D 10.1023/A:1016241927429 7494814
4. Hilfiker R, Blatter F, Raumer MV. Relevance of solid-state properties for pharmaceutical products. In: Hilfiker R, editor. Polymorphism in the pharmaceutical industry. Weinheim: Wiley-VCH; 2006. p. 1-19.
5. AR Sheth DJW Grant 2005 Relationship between the structure and properties of pharmaceutical crystals Kona 23 39 47
6. HN De Armas OM Peeters GV Den Mooter N Blaton 2007 Polymorphism of alprazolam (Xanax®): a review of its crystalline phases and identification, crystallographic characterization and crystal structure of a new polymorph (form III) J Pharm Sci 96 1114 30 10.1002/jps.20930 17455340 (Pubitemid 46804581)
7. D Singh PV Marshall L Shields P York 2000 Solid-state characterization of chlordiazepoxide polymorphs J Pharm Sci 87 655 62 10.1021/js960385c
8. Hilfiker R, editor. Polymorphism in pharmaceutical industry. Weinheim: Wiley-VCH. p. 414.
9. Bernstein J, editor. Polymorphism in molecular crystals. Oxford: Oxford University Press. p. 410.
10. C Rustichellia G Gamberini V Feriolia MC Gamberinia R Ficarrab S Tommasinic 2000 Solid state study of polymorphic drug: carbamazepine J Pharm Biomed Anal 23 41 54 10.1016/S0731-7085(00)00262-4 (Pubitemid 30394550)
11. C Van Tonder MD Mahlatji SF Malan W Liebenberg MR Caira M Song, et al. 2004 Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate AAPS Pharm Sci Tech 5 Article 12 10.1007/BF02830580
12. R Chadha P Arora R Kaur A Saini ML Singla DVS Jain 2009 Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques Acta Pharm 59 245 7 1:CAS:528:DC%2BD1MXhtlWjtb3F 10.2478/v10007-009-0024-9 19819822
13. C McGregor MH Saunders MH Buckton RD Saklatvala 2004 The use of high-speed differential scanning calorimetry (Hyper-DSC™) to study the thermal properties of carbamazepine polymorphs Thermochim Acta 417 231 7 1:CAS:528:DC%2BD2cXmtFyju7Y%3D 10.1016/j.tca.2003.09.031
14. SR Byrn RR Pfeiffer G Stephenson DJW Grant WB Gleason 1994 Solid state pharmaceutical chemistry Chem Mater 6 1148 58 1:CAS:528:DyaK2cXltFOnsbw%3D 10.1021/cm00044a013
15. HG Brittain 1997 Spectral methods for the characterization of polymorphs and solvates J Pharm Sci 86 405 12 1:CAS:528:DyaK2sXhslamt7g%3D 10.1021/js960238e 9109040 (Pubitemid 27154753)
16. DE Bugay 2001 Characterization of the solid-state: spectroscopic techniques Adv Drug Deliv Rev 48 43 65 1:CAS:528:DC%2BD3MXivFejsrk%3D 10.1016/S0169-409X(01)00101-6 11325476 (Pubitemid 32452291)
17. D Giron 1999 Thermal analysis, microcalorimetry and combined techniques for the study of pharmaceuticals J Therm Anal Calorim 56 1285 304 1:CAS:528:DyaK1MXnt1Wmsrk%3D 10.1023/A:1010194020563
18. D Giron 2002 Applications of thermal analysis and coupled techniques in pharmaceutical industry J Therm Anal Calorim 68 335 57 1:CAS:528: DC%2BD38XkvFehurk%3D 10.1023/A:1016015113795 (Pubitemid 34614439)
19. K Urakami 2005 Characterization of pharmaceutical polymorphs by isothermal calorimetry Curr Pharm Biotechnol 6 193 203 1:CAS:528: DC%2BD2MXmsVehtLg%3D 10.2174/1389201054022904 15974974 (Pubitemid 40933055)
20. MR Yadav AR Shaikh V Ganesan R Giridhar R Chadha 2008 Studies on the crystal forms of pefloxacin: preparation, characterization and dissolution profile J Pharm Sci 97 2637 2648 1:CAS:528:DC%2BD1cXotF2mu7o%3D 10.1002/jps.21178 17854073
21. Budavari S, editor. The Merck index, an encyclopedia of chemicals, drugs, and biological. Rahway: Merck; 1996. p. 1114.
22. NA Kasim M Whitehouse C Ramachandran M Bermejo H Lennernas AS Hussain, et al. 2004 Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Mol Pharm 1 85 96 1:CAS:528: DC%2BD3sXpvVSmsb8%3D 10.1021/mp034006h 15832504
23. MJ Lamson JP Sabo TR MacGregor JW Pav L Rowland A Hawi, et al. 1999 Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers Biopharm Drug Dispos 20 285 91 1:CAS:528:DC%2BD3cXhtVShsbc%3D 10.1002/(SICI)1099-081X(199909)20:6<285::AID-BDD187>3.0.CO;2-V 10701699 (Pubitemid 30071750)
24. BG Pereira FD Fonte-Boa JALC Resende CB Pinheiro NG Fernandes MI Yoshida CD Vianna-Soares 2007 Pseudopolymorphs and intrinsic dissolution of nevirapine Cryst Growth Des 7 2016 23 1:CAS:528:DC%2BD2sXhtVWisL7N 10.1021/cg0704495
25. RS Babra PP Christopher J Adivaraha JM Adam RH Nair 2004 General principles of pharmaceutical solid polymorphism: a supramolecular perspective Adv Drug Deliv Rev 56 241 74 10.1016/j.addr.2003.10.005 (Pubitemid 38201425)
26. Reguri BR, Chakka R. Crystalline forms of nevirapine. United States Patent 0183738 A1 (2006). Accessed 17 August 2006.
27. Reguri BR, Chakka R. Novel crystalline forms of 11-cyclopropyl-5,11- dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one (Nevirapine). United States Patent 0059653A1 (2005). Accessed 17 March 2005.
28. M Sarkar OP Perumal R Panchagnula 2008 Solid-state characterization of nevirapine Int J Pharm Sci 70 619 30 10.4103/0250-474X.45401
29. MR Caira N Stieger W Liebenberg MM De Villiers H Samsodien 2008 Solvent inclusion by the anti-HIV drug nevirapine: X-ray structures and thermal decomposition of representative solvates Cryst Growth Des 8 17 23 1:CAS:528:DC%2BD2sXhsVWgu7zJ 10.1021/cg070522r
30. Christian GD. Analytical chemistry. 4th ed. New York: Wiley; 1986.
31. D Giron 1995 Thermal analysis and calorimetric methods in the characterization of polymorphs and solvates Thermochim Acta 248 1 59 1:CAS:528:DyaK2MXivVOrtr8%3D 10.1016/0040-6031(94)01953-E
32. D Giron C Goldbronn M Mutz S Pfeffer P Piechon P Schwab 2002 Solid state characterization of pharmaceutical hydrates J Therm Anal 68 453 65 1:CAS:528:DC%2BD38XkvFegsrw%3D 10.1023/A:1016031517430 (Pubitemid 34614446)
33. A Kristl S Srcic F Vrecer B Sustar D Vojnovic 1996 Polymorphism and pseudopolymorphism: influencing the dissolution properties of the guanine derivative acyclovir Int J Pharm 139 231 5 1:CAS:528:DyaK28XkvFWgu70%3D 10.1016/0378-5173(96)04601-7 (Pubitemid 26276287)
34. RK Khankuri DJW Grant 1995 Pharmaceutical hydrates Thermochim Acta 248 61 79 10.1016/0040-6031(94)01952-D
35. A Othman JSO Evans IR Evans RK Harris 2007 Structural study of polymorphs and solvates of finasteride J Pharm Sci 96 1380 97 1:CAS:528: DC%2BD2sXltVGqtLo%3D 10.1002/jps.20940 17455354 (Pubitemid 46797496)
36. MR Caira G Bettinetti M Sorrenti L Catenacci 2007 Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of Brodimoprim J Pharm Sci 96 996 1007 1:CAS:528:DC%2BD2sXltVGqsrk%3D 10.1002/jps.20934 17455357 (Pubitemid 46797471)
37. MR Caira G Bettinetti M Sorrenti 2002 Structural relationships, thermal properties and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim J Pharm Sci 91 467 81 1:CAS:528: DC%2BD38XhsVSms7o%3D 10.1002/jps.10034 11835206 (Pubitemid 34137368)
38. MA White MI Mac Lean 1985 Rotational freedom of guest molecule in tetrahydrofuran clathrate as determined by heat capacity measurements J Phys Chem 89 1380 3 1:CAS:528:DyaL2MXhsFGis70%3D 10.1021/j100254a014
39. L Glasser HDB Jenkins 2007 The thermodynamic solvate difference rule: solvation parameters and their use in interpretation of the role of bound solvent in condensed phase solvates Inorg Chem 46 9768 78 1:CAS:528: DC%2BD2sXhtFCisbjJ 10.1021/ic701105p 17929806
40. CH Gu DJW Grant 2001 Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data J Pharm Sci 90 1277 87 1:CAS:528:DC%2BD3MXmvFGjsrk%3D 10.1002/jps.1080 11745780 (Pubitemid 32867976)
41. KR Brower J Peslak Jr J Elrod 1969 A correlation of molecular flexibility with volume and heat of mixing of organic solutes with water and glycol-water mixture J Phys Chem 78 207 11 10.1021/j100721a033
42. A Wakisaka H Abdoul-Carime Y Yamamoto Y Kiyozumi 1998 Non-ideality of binary mixtures: water.methanol and water.acetonitrile from the viewpoint of clustering structure J Chem Soc 94 369 374 1:CAS:528:DyaK1cXmslKltQ%3D%3D
43. -1 Can J Chem 55 1354 1359 1:CAS:528:DyaE2sXltVOns7o%3D 10.1139/v77-187
44. I Nagata K Tamura 1985 Excess enthalpies of binary and ternary mixtures of acetonitrile with methanol, ethanol and benzene Fluid Phase Equilib 24 289 306 1:CAS:528:DyaL28XhtFaktg%3D%3D 10.1016/0378-3812(85)85010-X (Pubitemid 16459835)
45. PP Singh BR Sharma KS Sidhu 1979 Thermodynamics of chloroform and methanol mixtures Can J Chem 57 387 93 1:CAS:528:DyaE1MXhs1Ortb8%3D 10.1139/v79-065
46. S Parveen S Singh D Shukla M Gupta JP Shukla 2009 Molecular interaction study of binary mixtures of THF with methanol and o-cresol-an optical and ultrasonic study Acta Phys Pol A 116 1011 1017 1:CAS:528:DC%2BC3cXhslakurk%3D
47. JY Coxam 1995 Excess enthalpies of (toluene+methanol or heptane or ethylcyclohexane) and of (heptanes+methylcyclohexane) at the temperatures 255.4 K and 310.9 K and the pressure 13.8 MPa J Chem Thermodynamics 27 1133 9 1:CAS:528:DyaK2MXos1yktLY%3D 10.1006/jcht.1995.0117
48. Reddick JA, Bunger WB, Sankano TK. Organic solvents: physical properties and methods of purification. In: Weissberger A, editor. Techniques of chemistry, vol II, 4th ed. Terre Haute: Wiley Interscience; 1986. p. 73-730.